Powder: -20°C for 3 years | In solvent: -80°C for 1 year
G-744 is a selective and orally active inhibitor of Btk (IC50: 2 nM). G-744 is well-tolerated, metabolically stable. It also has an efficacious to treat arthritis.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 10-14 weeks | $ 2,870.00 | |
50 mg | 10-14 weeks | $ 3,780.00 | |
100 mg | 10-14 weeks | $ 5,200.00 |
Description | G-744 is a selective and orally active inhibitor of Btk (IC50: 2 nM). G-744 is well-tolerated, metabolically stable. It also has an efficacious to treat arthritis. |
Targets&IC50 | CD86:64 nM, BTK:2 nM |
In vivo | G-744 (6.25/12.25/25 mg/kg, p.o., b.i.d., daily) treatment can prevent Lewis rats from collagen-induced arthritis, as a dose-dependently. |
Molecular Weight | 527.64 |
Formula | C29H29N5O3S |
CAS No. | 1346669-54-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
G-744 1346669-54-2 Angiogenesis Tyrosine Kinase/Adaptors BTK G 744 G744 inhibitor inhibit